About Blueprint Genetics
Blueprint Genetics is a Healthcare company based in Espoo (Finland) founded in 2012 by Juha Koskenvuo, Samuel Myllykangas, and Tero Pekka Alastalo, and was acquired by Quest Diagnostics in January 2020. Genetic diagnostics and clinical interpretation for hereditary diseases are provided. Blueprint Genetics has raised $19.86 million across 2 funding rounds from investors including Quest Diagnostics, Creathor Venture and MTIP. Its website blueprintgenetics.com draws about 41 thousand monthly visits. Blueprint Genetics offers products and services including Whole Exome Sequencing, Diagnostic Panels, Nucleus Platform, and Single Gene Tests. Its focus areas include Life Sciences, Clinical Genomics, Sequencing Based and Genetic Testing. Its legal entity is Blueprint Genetics Oy.
Company details
Blueprint Genetics was founded in 2012 in Espoo, Finland, as a provider in the genetic diagnostics sector. Comprehensive next-generation sequencing (NGS) services, including targeted panels, whole exome analysis, and copy number variation (CNV) detection, are offered for hereditary conditions. Coverage extends to over 2,000 genes, with applications in areas such as cardiovascular, neurological, metabolic, and hereditary cancer diagnostics. Clinical-grade interpretation and medical statements are included in the offerings.
- Headquarters Espoo, Finland
- Founders Juha Koskenvuo, Samuel Myllykangas, Tero Pekka Alastalo
- Stage Acquired
- SectorsHealthcare
- Website blueprintgenetics.com
- Social LinkedIn X Facebook
- Acquired by Quest Diagnostics (Jan 2020)
- Legal Name Blueprint Genetics Oy
- Total Equity Funding$19.86M (USD)
in 2 rounds
- Latest Funding Round$15.96M (USD), Series B
Jul 2017
- InvestorsQuest Diagnostics
& 4 more
- Acquired byQuest Diagnostics
(Jan 2020)
Products & Services of Blueprint Genetics
Blueprint Genetics offers a comprehensive portfolio of products and services, including Whole Exome Sequencing, Diagnostic Panels, Nucleus Platform, and Single Gene Tests.
Comprehensive sequencing of protein-coding genes for diagnostic purposes
Targeted tests for specific medical conditions like cardiology
Online tool for clinicians to order and manage genetic tests
Analysis of individual genes for variant detection
Funding Insights of Blueprint Genetics
Blueprint Genetics has successfully raised a total of $19.86M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $15.96 million completed in July 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $19.86M
- Total Rounds 2
- Last Round Series B — $15.96M
- First Round $3.9M
(Aug 2014)
- Investors Count 4
All 2 funding rounds of Blueprint Genetics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2017 | $15.96M | Series B | – | Creathor Venture, MTIP | |
| Aug 2014 | $3.9M | Series A | – | Inventure | – |
5 investors in total: 5 institutional.
Investors in Blueprint Genetics
Blueprint Genetics has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Quest Diagnostics, Creathor Venture and MTIP.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| creathor.com | ||||
Venture capital fund focused on digital health and digital medical device companies | mtip.ch | Basel, Switzerland | ||
Pontos Group is engaged in long-term investment management. | pontos.fi | Helsinki, Finland | ||
Investments in early-stage tech startups are made by Inventure. | inventure.vc | Helsinki, Finland | ||
Integrated diagnostic and IT services are provided to healthcare organizations. | 1967 | questdiagnostics.com | Madison, United States |
Investor details for Blueprint Genetics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Blueprint Genetics
13 people are tracked at Blueprint Genetics (4 in leadership, 9 in team).
| Name | Role | Group |
|---|---|---|
Juha Koskenvuo | Co-Founder | Leadership |
Samuel Myllykangas | Co-Founder | Leadership |
Tero Pekka Alastalo | Co-Founder | Leadership |
Sari Tuupanen | Genetics Director | Leadership |
Mae Dallal | Genomic Client Services Specialist | Team |
Mikko Muona | Clinical Bioinformatics Manager | Team |
Alicia Scocchia | Clinical Liaison | Team |
Julie Hathaway | Clinical Liaison | Team |
Hanna Allen | Marketing Manager, Global | Team |
Wayne Davies | Technical Specialist | Team |
Wen Jun Fu | Product Specialist | Team |
Minnamari Salmela | Senior Quality Specialist | Team |
Kim Gall | Senior Manager, Genomic Services | Team |
Complete people profiles for Blueprint Genetics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Blueprint Genetics
4 dated milestones of Blueprint Genetics across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Blueprint Genetics is founded.
- Funding First funding round of $3.9M.
- Funding Latest funding round, Series B, of $16.0M.
- Exit Acquired by Quest Diagnostics.
Web traffic of Blueprint Genetics
The website of Blueprint Genetics (blueprintgenetics.com) receives about 40.7K visits a month.
- Monthly visits40.7K
▲ 32.2% vs previous month
Websites whose visitors overlap most with Blueprint Genetics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| preventiongenetics.com | 100% | 24.4K | #1,074,192 | View details | |
| ehlers-danlos.org | 87% | #409,766 | View details | ||
msac.gov.au | msac.gov.au | 83% | #1,888,616 | – | |
| invitae.com | 80% | 439.4K | #95,124 | View details | |
| ambrygen.com | 80% | 189.2K | #206,714 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 21 similar websites and full traffic analytics for Blueprint Genetics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 21 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Blueprint Genetics
Complete news archive for Blueprint Genetics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Blueprint Genetics
Blueprint Genetics was founded in 2012 and raised its 1st funding round 2 years after it was founded.
Blueprint Genetics is headquartered in Espoo, Finland.
Blueprint Genetics is a funded company, having raised a total of $19.86M across 2 funding rounds to date. The company's 1st funding round was a Series A of $3.9M, raised on Aug 2014.
Blueprint Genetics was founded in 2012 in Espoo, Finland, as a provider in the genetic diagnostics sector. Comprehensive next-generation sequencing (NGS) services, including targeted panels, whole exome analysis, and copy number variation (CNV) detection, are offered for hereditary conditions. Coverage extends to over 2,000 genes, with applications in areas such as cardiovascular, neurological, metabolic, and hereditary cancer diagnostics. Clinical-grade interpretation and medical statements are included in the offerings.
Blueprint Genetics offers Whole Exome Sequencing, Diagnostic Panels, Nucleus Platform, and Single Gene Tests.
Blueprint Genetics has 5 investors. Key investors include Quest Diagnostics, Creathor Venture, MTIP, Pontos Group, and Inventure VC.
Blueprint Genetics operates through Blueprint Genetics Oy.
Yes. Blueprint Genetics was acquired by Quest Diagnostics in January 2020.